Quidel shares soar as Q2 results beat estimates, cost-saving initiatives pay off

Published 05/08/2025, 22:36
Quidel shares soar as Q2 results beat estimates, cost-saving initiatives pay off

Investing.com -- QuidelOrtho Corporation (NASDAQ:QDEL) shares surged 7.4% after the in-vitro diagnostic technologies provider reported second-quarter earnings that beat analyst expectations, driven by successful cost-saving initiatives and solid commercial execution despite lower respiratory and COVID-19 revenue.

The company reported adjusted earnings per share of $0.12 for the second quarter, significantly outperforming the analyst consensus estimate of $0.00. Revenue came in at $614 million, exceeding the consensus estimate of $609.92 million, though it represented a decrease from $637 million in the same quarter last year.

"Our second quarter results demonstrate our continuing commitment to commercial and operational execution," said Brian J. Blaser, President and Chief Executive Officer of QuidelOrtho. "Our team delivered solid top and bottom-line results while also navigating a challenging global environment."

The company’s non-respiratory revenue was $567 million, decreasing 2% YoY both as reported and in constant currency. However, excluding Donor Screening, non-respiratory revenue grew 1% in constant currency, with Labs revenue increasing 4% as reported (5% in constant currency) and Immunohematology revenue growing 4% as reported (3% in constant currency).

Respiratory revenue fell 20% to $47 million, primarily due to lower COVID-19 revenue compared to the prior year period. Despite this decline, the company achieved a significant improvement in profitability, with adjusted EBITDA margin reaching 17%, a 330 basis point improvement from the previous year, driven by the company’s cost-savings initiatives.

QuidelOrtho reaffirmed its full-year 2025 guidance, projecting revenue between $2.60 billion and $2.81 billion, compared to the analyst consensus of $2.72 billion. The company expects adjusted EPS of $2.07 to $2.57, against a consensus estimate of $2.40.

The strong market reaction reflects investor confidence in the company’s ability to execute its strategic initiatives, including realizing $100 million in annualized cost-savings and initiating a major manufacturing site consolidation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.